US2011229477A1PendingUtilityA1
Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy
Individually held — no corporate assignee on recordPriority: Nov 24, 1997Filed: Jun 3, 2011Published: Sep 22, 2011
Est. expiryNov 24, 2017(expired)· nominal 20-yr term from priority
Inventors:Johnson Wong
A61K 38/2013A61K 38/162C12N 2501/06C12N 2501/23A61K 39/39541A61K 31/7072C12N 2501/505A61K 38/2006C07K 2317/31A61K 38/191A61K 2039/505A61K 39/395C07K 16/2809A61K 31/4412A61K 38/168A61P 31/18A61K 31/708C12N 2501/515C07K 16/2815A61K 40/46A61K 40/11A61K 2239/31C12N 5/0636
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a method for treating infection with a pathogen. The method involves administration of (1) a substance which induces active pathogen replication in a cell latently infected with HIV and (2) an anti-pathogen drug. Also disclosed are methods for expanding CD4+ T cells from peripheral blood mononuclear cells isolated from human subjects in the presence of an antiretroviral drug and for treating HIV infection by infusing the expanded CD4+ cells into HIV-infected patients.
Claims
exact text as granted — not AI-modified1 . A method of treating a patient infected with HIV, comprising administering to said patient an amount of a T cell mitogen sufficient to induce activation of CD4+ T cells and replication of HIV within latently infected T cells and a therapeutically effective amount of an anti-retroviral drug.
2 - 21 . (canceled)Join the waitlist — get patent alerts
Track US2011229477A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.